Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says

[cafead]

via The U.S. Food and Drug Administration website showed that most doses of Eli Lilly's (LLY.N) diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand.

article source